Full Text
The Emerging Role Of Patient-Reported Outcomes (Pros) In Fda Hematology And Oncology Product Labels

Abstract

Authors

J. Tse S.L. Shingler A. Nixon

Back to Volume 18, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×